nodes	percent_of_prediction	percent_of_DWPC	metapath
Anisotropine Methylbromide—Valproic Acid—PTGS1—breast cancer	0.0293	0.412	CrCbGaD
Anisotropine Methylbromide—Valproic Acid—CYP3A4—breast cancer	0.0171	0.241	CrCbGaD
Anisotropine Methylbromide—Ipratropium bromide—CYP2D6—breast cancer	0.0133	0.187	CrCbGaD
Anisotropine Methylbromide—Ipratropium bromide—CYP3A4—breast cancer	0.0114	0.16	CrCbGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ITPR1—breast cancer	0.000233	0.000251	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—MTHFR—breast cancer	0.000232	0.00025	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—STAT5A—breast cancer	0.000231	0.000249	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ERBB4—breast cancer	0.000231	0.000249	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MMP3—breast cancer	0.000231	0.000249	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3CB—breast cancer	0.000231	0.000248	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SMAD4—breast cancer	0.000227	0.000244	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SMAD4—breast cancer	0.000226	0.000244	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IGF1R—breast cancer	0.000226	0.000243	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IGF1R—breast cancer	0.000225	0.000242	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—CXCL8—breast cancer	0.000225	0.000242	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SMAD4—breast cancer	0.000224	0.000241	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—CXCL8—breast cancer	0.000224	0.000241	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IGF1R—breast cancer	0.000223	0.00024	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	0.000222	0.000239	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HES1—breast cancer	0.000222	0.000239	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HES1—breast cancer	0.000221	0.000238	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NCOR1—breast cancer	0.00022	0.000237	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PLA2G4A—breast cancer	0.00022	0.000237	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NCOR1—breast cancer	0.00022	0.000237	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PLA2G4A—breast cancer	0.00022	0.000237	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HES1—breast cancer	0.000219	0.000236	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FGF1—breast cancer	0.000218	0.000235	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CSF2—breast cancer	0.000218	0.000235	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	0.000218	0.000234	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NCOR1—breast cancer	0.000218	0.000234	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—RAF1—breast cancer	0.000217	0.000234	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CSF2—breast cancer	0.000217	0.000234	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FGF1—breast cancer	0.000217	0.000234	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—RAF1—breast cancer	0.000217	0.000233	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NRG1—breast cancer	0.000216	0.000233	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NRG1—breast cancer	0.000216	0.000232	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CSF2—breast cancer	0.000215	0.000232	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FGF1—breast cancer	0.000215	0.000232	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—H2AFX—breast cancer	0.000215	0.000231	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—IL2—breast cancer	0.000215	0.000231	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—RAF1—breast cancer	0.000215	0.000231	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CAV1—breast cancer	0.000214	0.000231	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—H2AFX—breast cancer	0.000214	0.000231	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—IL2—breast cancer	0.000214	0.00023	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NRG1—breast cancer	0.000214	0.00023	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—E2F1—breast cancer	0.000213	0.00023	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—E2F1—breast cancer	0.000213	0.000229	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	0.000212	0.000229	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—H2AFX—breast cancer	0.000212	0.000228	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—IL2—breast cancer	0.000212	0.000228	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	0.000212	0.000228	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—E2F1—breast cancer	0.000211	0.000227	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	0.00021	0.000226	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SPP1—breast cancer	0.000205	0.000221	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SPP1—breast cancer	0.000204	0.00022	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—CXCL8—breast cancer	0.000204	0.00022	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—CXCL8—breast cancer	0.000203	0.000219	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ERBB3—breast cancer	0.000203	0.000218	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FGFR2—breast cancer	0.000202	0.000218	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SPP1—breast cancer	0.000202	0.000218	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ERBB3—breast cancer	0.000202	0.000218	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FGFR2—breast cancer	0.000202	0.000217	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—CXCL8—breast cancer	0.000201	0.000217	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ERBB3—breast cancer	0.0002	0.000215	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FGFR2—breast cancer	0.0002	0.000215	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CG—breast cancer	0.000195	0.00021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—IL2—breast cancer	0.000195	0.00021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—IL2—breast cancer	0.000194	0.000209	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TERT—breast cancer	0.000194	0.000209	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TERT—breast cancer	0.000194	0.000208	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—IL2—breast cancer	0.000192	0.000207	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TERT—breast cancer	0.000192	0.000206	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FGFR1—breast cancer	0.000189	0.000203	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FGFR1—breast cancer	0.000188	0.000202	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FGFR1—breast cancer	0.000186	0.0002	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HIF1A—breast cancer	0.000186	0.0002	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HIF1A—breast cancer	0.000185	0.000199	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HIF1A—breast cancer	0.000183	0.000197	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—LEP—breast cancer	0.000181	0.000195	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—LEP—breast cancer	0.000181	0.000195	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CAV1—breast cancer	0.00018	0.000193	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CAV1—breast cancer	0.000179	0.000193	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—LEP—breast cancer	0.000179	0.000193	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—KDR—breast cancer	0.000178	0.000191	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CAV1—breast cancer	0.000177	0.000191	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—KDR—breast cancer	0.000177	0.000191	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—KDR—breast cancer	0.000175	0.000189	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ESR1—breast cancer	0.000173	0.000186	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ESR1—breast cancer	0.000173	0.000186	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CD—breast cancer	0.000172	0.000185	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FN1—breast cancer	0.000171	0.000184	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ESR1—breast cancer	0.000171	0.000184	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FN1—breast cancer	0.00017	0.000184	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—ALB—breast cancer	0.000169	0.000182	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NFKBIA—breast cancer	0.000169	0.000182	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FN1—breast cancer	0.000169	0.000182	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NFKBIA—breast cancer	0.000168	0.000181	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NOTCH1—breast cancer	0.000167	0.00018	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NOTCH1—breast cancer	0.000167	0.00018	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NFKBIA—breast cancer	0.000167	0.00018	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NOTCH1—breast cancer	0.000165	0.000178	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—KIT—breast cancer	0.000164	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—APC—breast cancer	0.000164	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CG—breast cancer	0.000164	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CG—breast cancer	0.000163	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—APC—breast cancer	0.000163	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—KIT—breast cancer	0.000163	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—NOS3—breast cancer	0.000162	0.000174	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—EGF—breast cancer	0.000162	0.000174	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—KIT—breast cancer	0.000162	0.000174	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CG—breast cancer	0.000162	0.000174	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—APC—breast cancer	0.000162	0.000174	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—EGF—breast cancer	0.000161	0.000174	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—EGF—breast cancer	0.00016	0.000172	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—MAPK3—breast cancer	0.000157	0.000169	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—MAPK3—breast cancer	0.000156	0.000168	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—MAPK3—breast cancer	0.000155	0.000167	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—BRAF—breast cancer	0.000154	0.000166	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—BRAF—breast cancer	0.000153	0.000165	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—BRAF—breast cancer	0.000152	0.000163	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IGF1—breast cancer	0.00015	0.000161	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AKT2—breast cancer	0.00015	0.000161	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CB—breast cancer	0.000149	0.000161	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IGF1—breast cancer	0.000149	0.000161	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AKT2—breast cancer	0.000149	0.000161	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—EGFR—breast cancer	0.000149	0.000161	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—EGFR—breast cancer	0.000149	0.00016	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PTGS2—breast cancer	0.000148	0.000159	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IGF1—breast cancer	0.000148	0.000159	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AKT2—breast cancer	0.000148	0.000159	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—EGFR—breast cancer	0.000147	0.000158	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CD—breast cancer	0.000144	0.000155	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CD—breast cancer	0.000143	0.000154	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	0.000142	0.000153	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SERPINE1—breast cancer	0.000142	0.000153	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	0.000142	0.000153	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CD—breast cancer	0.000142	0.000153	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SERPINE1—breast cancer	0.000142	0.000153	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—KRAS—breast cancer	0.000141	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	0.000141	0.000151	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SERPINE1—breast cancer	0.00014	0.000151	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—KRAS—breast cancer	0.00014	0.000151	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—KRAS—breast cancer	0.000139	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NOS3—breast cancer	0.000136	0.000146	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NOS3—breast cancer	0.000135	0.000146	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NOS3—breast cancer	0.000134	0.000144	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	0.000129	0.000139	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PTEN—breast cancer	0.000129	0.000139	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	0.000129	0.000139	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MDM2—breast cancer	0.000129	0.000139	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MDM2—breast cancer	0.000128	0.000138	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—RAF1—breast cancer	0.000128	0.000138	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—RAF1—breast cancer	0.000128	0.000138	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—RELA—breast cancer	0.000128	0.000138	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	0.000128	0.000138	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—RELA—breast cancer	0.000127	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MDM2—breast cancer	0.000127	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ERBB2—breast cancer	0.000127	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—RAF1—breast cancer	0.000127	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ERBB2—breast cancer	0.000127	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—RELA—breast cancer	0.000126	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ERBB2—breast cancer	0.000125	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CB—breast cancer	0.000125	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MTOR—breast cancer	0.000125	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CB—breast cancer	0.000125	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MTOR—breast cancer	0.000125	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MTOR—breast cancer	0.000124	0.000133	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CB—breast cancer	0.000124	0.000133	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CXCL8—breast cancer	0.000121	0.00013	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CXCL8—breast cancer	0.00012	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—HRAS—breast cancer	0.00012	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—HRAS—breast cancer	0.000119	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CXCL8—breast cancer	0.000119	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—HRAS—breast cancer	0.000118	0.000127	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CDKN1B—breast cancer	0.000118	0.000127	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CDKN1B—breast cancer	0.000117	0.000126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—AKT1—breast cancer	0.000116	0.000125	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CDKN1B—breast cancer	0.000116	0.000125	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—AKT1—breast cancer	0.000116	0.000125	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CASP3—breast cancer	0.000115	0.000124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IL2—breast cancer	0.000115	0.000124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CASP3—breast cancer	0.000115	0.000124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—AKT1—breast cancer	0.000115	0.000124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IL2—breast cancer	0.000115	0.000124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—IL6—breast cancer	0.000115	0.000123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—IL6—breast cancer	0.000114	0.000123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CASP3—breast cancer	0.000114	0.000123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IL2—breast cancer	0.000114	0.000122	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—IL6—breast cancer	0.000113	0.000122	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCND1—breast cancer	0.000112	0.000121	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—JUN—breast cancer	0.000112	0.000121	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCND1—breast cancer	0.000112	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—JUN—breast cancer	0.000112	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CTNNB1—breast cancer	0.000111	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CTNNB1—breast cancer	0.000111	0.000119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCND1—breast cancer	0.000111	0.000119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—JUN—breast cancer	0.000111	0.000119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CTNNB1—breast cancer	0.00011	0.000118	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MMP9—breast cancer	0.000109	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MMP9—breast cancer	0.000109	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CDKN1A—breast cancer	0.000109	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PTEN—breast cancer	0.000108	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CDKN1A—breast cancer	0.000108	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PTEN—breast cancer	0.000108	0.000116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MMP9—breast cancer	0.000108	0.000116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CDKN1A—breast cancer	0.000107	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PTEN—breast cancer	0.000107	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MAPK8—breast cancer	0.000106	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—AKT1—breast cancer	0.000106	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MAPK8—breast cancer	0.000106	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—AKT1—breast cancer	0.000105	0.000113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MAPK8—breast cancer	0.000105	0.000113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—AKT1—breast cancer	0.000104	0.000112	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SRC—breast cancer	0.0001	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SRC—breast cancer	0.0001	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SRC—breast cancer	9.92e-05	0.000107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—VEGFA—breast cancer	9.79e-05	0.000105	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—VEGFA—breast cancer	9.76e-05	0.000105	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—STAT3—breast cancer	9.69e-05	0.000104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—VEGFA—breast cancer	9.66e-05	0.000104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—STAT3—breast cancer	9.66e-05	0.000104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—STAT3—breast cancer	9.57e-05	0.000103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MAPK3—breast cancer	9.26e-05	9.97e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MAPK3—breast cancer	9.23e-05	9.94e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MAPK3—breast cancer	9.14e-05	9.84e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CA—breast cancer	9.11e-05	9.81e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MYC—breast cancer	9e-05	9.7e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TGFB1—breast cancer	8.98e-05	9.67e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MYC—breast cancer	8.98e-05	9.66e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TGFB1—breast cancer	8.95e-05	9.64e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MYC—breast cancer	8.89e-05	9.57e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TGFB1—breast cancer	8.87e-05	9.55e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—EGFR—breast cancer	8.81e-05	9.48e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—EGFR—breast cancer	8.78e-05	9.45e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—EGFR—breast cancer	8.69e-05	9.36e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—KRAS—breast cancer	8.32e-05	8.96e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—KRAS—breast cancer	8.29e-05	8.93e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—KRAS—breast cancer	8.21e-05	8.84e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CA—breast cancer	7.64e-05	8.23e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CA—breast cancer	7.62e-05	8.2e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CA—breast cancer	7.55e-05	8.12e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—AKT1—breast cancer	7.44e-05	8.02e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TP53—breast cancer	7.4e-05	7.96e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TP53—breast cancer	7.37e-05	7.94e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TP53—breast cancer	7.3e-05	7.86e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HRAS—breast cancer	7.07e-05	7.61e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HRAS—breast cancer	7.05e-05	7.59e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HRAS—breast cancer	6.98e-05	7.52e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IL6—breast cancer	6.77e-05	7.29e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IL6—breast cancer	6.75e-05	7.26e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IL6—breast cancer	6.68e-05	7.19e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AKT1—breast cancer	6.24e-05	6.72e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AKT1—breast cancer	6.22e-05	6.7e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AKT1—breast cancer	6.16e-05	6.64e-05	CbGpPWpGaD
